Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2011-11-01

Clinical Trial Update: Oral Ketamine as an Adjuvant to Opioids for Pain Treatment in Cancer Patients [NA]

View source ↗

Summary

This document provides a clinical trial update describing the use of oral ketamine as an adjuvant to opioids for cancer-related pain management.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketamine (ketamine)

Snippet

Sponsor: Tel-Aviv Sourasky Medical Center | Conditions: Cancer, Pain | NA | Status: UNKNOWN